Effects of Dapagliflozin in Asian patient with HFrEF in DAPA-HF
Kieran F. Docherty, MB CHB, Inder S. Anand, MD, DPHIL, Chern-En Chiang, MD, PHD, Vijay K. Chopra, MD, Akshay S. Desai, MD, Masafumi Kitakaze, MD, PHD, Subodh Verma, MD, PHD, Pham N. Vinh, MD, PHD, Silvio E. Inzucchi, MD, Lars Køber, MD, DMSC, Mikhail N. Kosiborod, MD, Felipe A. Martinez, MD, Olof Bengtsson, PH LIC, Piotr Ponikowski, MD, PHD, Marc S. Sabatine, MD, MPH, Mikaela Sjöstrand, MD, PHD, Scott D. Solomon, MD, Anna Maria Langkilde, MD, PHD, Pardeep S. Jhund, MBCHB, MSC, PHD, John J.V. McMurray, MD. Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF. https://doi.org/10.1016/j.jacasi.2022.02.004Effects of Dapagliflozin in Asian patient with HFrEF in DAPA-HF
Để lại bình luận
Bạn cần phải đăng nhập để đăng bình luận.